SI-BONE SIBN
SI-BONE, Inc. · Nasdaq · Surgical & Medical Instruments & Apparatus
$23.77+17.56%close on Nov. 3, 2026 · volume 3.3M · Yahoo Finance
Price, last 51 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Oct. 29, 2026 | Anshul Maheshwari Chief Op & Financial Officer | Sold 10b5-1 plan | 3,738 | $22.50 | $84,105 |
| Oct. 12, 2026 | Laura Francis Chief Executive Officer, director · indirect | Sold 10b5-1 plan | 38,006 | $20.05 | $762,013 |
| Oct. 5, 2026 | Anshul Maheshwari Chief Op & Financial Officer | Sold 10b5-1 plan | 1,731 | $19.50 | $33,754 |
| Oct. 2, 2026 | Michael A. Pisetsky SVP, Ops & Adm/Chief Legal Ofr | Sold | 3,133 | $18.17 $18.14-$18.20 | $56,918 |
| Oct. 2, 2026 | Anshul Maheshwari Chief Op & Financial Officer | Sold 10b5-1 plan | 3,318 | $18.18 $18.17-$18.19 | $60,325 |
| Oct. 1, 2026 | Jeffrey W. Dunn director | Sold | 20,000 | $18.47 | $369,400 |
| Sept. 1, 2026 | Jeffrey W. Dunn director | Sold 10b5-1 plan | 20,000 | $18.91 | $378,160 |
| Aug. 24, 2026 | Laura Francis Chief Executive Officer, director · indirect | Sold 10b5-1 plan | 25,972 | $20.12 | $522,596 |
| Aug. 24, 2026 | Anshul Maheshwari Chief Op & Financial Officer | Sold 10b5-1 plan | 11,636 | $20.11 | $233,971 |
| Aug. 21, 2026 | Laura Francis Chief Executive Officer, director · indirect | Sold 10b5-1 plan | 3,923 | $20.02 | $78,538 |
| Aug. 21, 2026 | Anshul Maheshwari Chief Op & Financial Officer | Sold 10b5-1 plan | 11,228 | $20.02 | $224,785 |
| Aug. 20, 2026 | Laura Francis Chief Executive Officer, director · indirect | Sold 10b5-1 plan | 51,884 | $19.46 | $1.01 million |
Latest 12 of 17. Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 22 →Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedSI-BONE Q3 2026 revenue of $55.7 million (+14.5%) and EPS of -$0.08 beat consensus; 2026 revenue guidance of $231M-$233M reaffirmed